Showing results (1-10 of 804) with videos related to
Sort By:
Pageof 81
Neurology|December 1, 1993
Psychosocial aspects of Parkinson's diseaseH Ellgring, S Seiler, B Perleth, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trialJ Schwarz, C Trenkwalder, T Gasser, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapyJ Schwarz, K Tatsch, T Gasser, et al.Archives of Neurology|November 1, 1992
Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's diseaseT Gasser, J Schwarz, G Arnold, et al.Advances in Neurology|January 1, 1993
IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndromeW H Oertel, J Schwarz, K Tatsch, et al.Neuropharmacology|July 1, 1992
The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosetsU Wüllner, A Kupsch, G Arnold, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonismJ Schwarz, K Tatsch, T Gasser, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effectsT E Eichhorn, T Gasser, N Mai, et al.Neurology|March 1, 1992
123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonismJ Schwarz, K Tatsch, G Arnold, et al.Journal of Neural Transmission. Supplementum|December 29, 2000
Autosomal-dominantly inherited forms of Parkinson's diseaseT GasserPageof 81